Genetic variation of the enzyme, adenosine deaminase (ADA), can be detected by starch gel electrophoresis of human red cell lysates and an appropriate staining procedure (Spencer, Hopkinson, and Harris, 1968). Three phenotypes (ADA 1, ADA 2-1, and ADA 2) appear to be determined by two structural alleles, ADA' and ADA2. The frequency of the less common allele, ADA2, was reported to be 0 03 and 0...

CD26 is a lymphocyte marker that can anchor adenosine deaminase (ADA) on the T cell surface. We found that ADA is regulated by cytokines on the cell surface during T cell activation. By means of flow cytometry, immunofluorescence, and immunoblotting techniques, we found that interleukin (IL)-2 and IL-12 up-regulate ecto-ADA and CD26 expression. In clear contrast, IL-4 led to down-regulation of ...

Deficiency of erythrocytic and lymphocytic adenosine deaminase (ADA) occurs in some patients with severe combined immunodeficiency disease (SCID). SCID with ADA deficiency is inherited as an autosomal recessive trait. ADA is markedly reduced or undetectable in affected patients (homozygotes), and approximately one-half normal levels are found in individuals heterozygous for ADA deficiency. The ...

Neurons immunoreactive for the enzyme adenosine deaminase (ADA) in the posterior basal hypothalamus of the rat have a distribution pattern similar to those immunoreactive for histidine decarboxylase (HDC) and are particularly numerous in the tuberal (TM), caudal (CM) and postmammillary caudal (PCM) hypothalamic magnocellular nuclei which harbor neurons containing glutamic acid decarboxylase (GA...

Genetic variation of the enzyme, adenosine deaminase (ADA), can be detected by starch gel electrophoresis of human red cell lysates and an appropriate staining procedure (Spencer, Hopkinson, and Harris, 1968). Three phenotypes (ADA 1, ADA 2-1, and ADA 2) appear to be determined by two structural alleles, ADA' and ADA2. The frequency of the less common allele, ADA2, was reported to be 0 03 and 0...

BACKGROUND This study was conducted to evaluate the feasibility of long-term adalimumab (ADA) discontinuation after achievement of low disease activity (LDA) in Japanese patients with early rheumatoid arthritis (RA) and to identify predictors of LDA maintenance. METHODS In the HOPEFUL-1 study, patients received initial therapy with either ADA plus methotrexate (MTX; intensive therapy) or MTX ...

1-Adamantanamine hydrochloride (Ada) has been reported to be an effective agent against influenza and rubella viruses (1-3). In the course of pharmacological study of Ada in this laboratory it was observed that the compound induced cardiac arrhythmia in rabbit. This was confirmed by Kaji et al. (4). In the present experiment, the mechanism of arrhythmia inducing action of Ada was studied using ...

The relationship between adenosine deaminase (ADA) and a human membrane thymus leukemia (HTL) antigen-detected by an antithymocyte serum was explored. A freeze-thaw extract of the T-cell-derived cell line, MOLT 4, was applied to an immunoabsorbant column of a rabbit antiserum to calf ADA. The bound MOLT 4 ADA was eluted with 6 M urea. The recovered ADA had a specific activity of 490 mumol of ad...

Intracellular adenosine deaminase (ADA), purine nucleoside phosphorylase (PNP) and terminal deoxynucleotidyl transferase (TdT) activities were investigated in adult patients with acute myelogenous leukemia (AML) in order to relate these enzymatic activities to the stage of differentiation and maturation and to the clinical outcome of AML. Both ADA and PNP were measured spectrophotometrically us...